Literaturverzeichnis
zum Titelthema „Drei Highlights aus der Augenheilkunde“ von Professor Dr. Ines Lanzl Bayerisches Ärzteblatt 10/2018, Seite 512 ff.
[1] Razeghinejad MR1, Myers JS, Katz LJ. Iatrogenic glaucoma secondary to medications.
Am J Med. 2011;124(1):20-5.
[2] Thulliez M1, Angoulvant D2, Le Lez ML1, Jonville-Bera AP3, Pisella PJ1, Gueyffier F4, Bejan-Angoulvant T5. Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis.
JAMA Ophthalmol. 2014;132(11):1317-26.
[3] Goto H, Zako M, Namba K, Hashida N, Kaburaki T, Miyazaki M, Sonoda KH, Abe T, Mizuki N, Kamoi K, Brézin AP, Dick AD, Jaffe GJ, Nguyen QD, Inomata N, Kwatra NV, Camez A, Song AP, Kron M, Tari S, Ohno S.
Adalimumab in Active and Inactive, Non-Infectious Uveitis: Global Results from the VISUAL I and VISUAL II Trials.
Ocul Immunol Inflamm. 2018;17:1-11.